X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hepatitis c (4) 4
index medicus (4) 4
interferon (4) 4
antiviral agents - administration & dosage (3) 3
boceprevir (3) 3
female (3) 3
genotype (3) 3
hepatitis (3) 3
hepatitis c, chronic - drug therapy (3) 3
humans (3) 3
male (3) 3
middle aged (3) 3
ribavirin - administration & dosage (3) 3
telaprevir (3) 3
treatment outcome (3) 3
abridged index medicus (2) 2
adolescent (2) 2
adult (2) 2
aged (2) 2
antiviral agents (2) 2
clinical trials (2) 2
double-blind method (2) 2
drug administration schedule (2) 2
drug therapy (2) 2
genetic aspects (2) 2
health aspects (2) 2
interferon-alpha - administration & dosage (2) 2
internal medicine (2) 2
medicine, general & internal (2) 2
patient outcomes (2) 2
polyethylene glycols - administration & dosage (2) 2
product development (2) 2
recombinant proteins - administration & dosage (2) 2
ribavirin (2) 2
sofosbuvir (2) 2
triple therapy (2) 2
uridine monophosphate - administration & dosage (2) 2
uridine monophosphate - analogs & derivatives (2) 2
alpha-2a (1) 1
analysis (1) 1
antiviral agents - adverse effects (1) 1
antiviral agents - therapeutic use (1) 1
association (1) 1
benzimidazoles - administration & dosage (1) 1
biological response modifiers (1) 1
care and treatment (1) 1
cirrhosis (1) 1
combination (1) 1
digestive system diseases (1) 1
double-blind (1) 1
drug combinations (1) 1
drug therapy, combination (1) 1
drug therapy, combination - methods (1) 1
elbasvir (1) 1
fluorenes - administration & dosage (1) 1
gastroenterology & hepatology (1) 1
gastrointestinal diseases (1) 1
genotypes (1) 1
grazoprevir (1) 1
headache (1) 1
headache - chemically induced (1) 1
hepacivirus - classification (1) 1
hepacivirus - genetics (1) 1
hepacivirus - pathogenicity (1) 1
hepatitis c virus (1) 1
hepatitis c, chronic - genetics (1) 1
hepatitis c, chronic - virology (1) 1
heterocyclic compounds, 3-ring - administration & dosage (1) 1
in-vitro (1) 1
infection (1) 1
infectious disease (1) 1
infectious diseases (1) 1
inhibitor (1) 1
inhibitors (1) 1
interferon alpha (1) 1
interferon-alpha - therapeutic use (1) 1
liver (1) 1
liver cirrhosis (1) 1
liver cirrhosis - pathology (1) 1
liver diseases (1) 1
management (1) 1
methods (1) 1
mortality (1) 1
nausea - chemically induced (1) 1
ns5a (1) 1
once-daily tmc435 (1) 1
one pill (1) 1
original (1) 1
original article (1) 1
original articles (1) 1
patients (1) 1
peginterferon alpha-2b (1) 1
plus ribavirin (1) 1
polyethylene glycols - therapeutic use (1) 1
protease inhibitors (1) 1
protease inhibitors - therapeutic use (1) 1
proteases (1) 1
proteinase inhibitors (1) 1
psi-7977 (1) 1
recombinant proteins - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 5, pp. 401 - 408
Summary Background Protease inhibitors have improved treatment of infection with hepatitis C virus (HCV), but dosing, a low barrier to resistance, drug... 
Infectious Disease | PSI-7977 | INFECTIOUS DISEASES | PLUS RIBAVIRIN | VIRUS-INFECTION | TELAPREVIR | BOCEPREVIR | INHIBITORS | Recombinant Proteins - therapeutic use | Uridine Monophosphate - administration & dosage | Nausea - chemically induced | Humans | Middle Aged | Hepatitis C, Chronic - virology | Hepacivirus - pathogenicity | Male | Secondary Prevention | Polyethylene Glycols - therapeutic use | Young Adult | Time Factors | Ribavirin - administration & dosage | Adult | Female | Headache - chemically induced | Uridine Monophosphate - therapeutic use | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | RNA, Viral - analysis | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Interferon-alpha - administration & dosage | Drug Therapy, Combination - methods | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Adolescent | Liver Cirrhosis - pathology | Aged | Hepacivirus - classification | Sofosbuvir | Care and treatment | Protease inhibitors | Proteases | Gastrointestinal diseases | Clinical trials | Product development | Genetic aspects | Interferon | Hepatitis C | Health aspects | Liver cirrhosis | Viral antigens
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9941, pp. 414 - 426
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.